Custom mRNA vaccine aims to stop liver cancer recurrence after surgery
Disease control
Recruiting now
This study tests a personalized mRNA vaccine (iNeo-Vac-R01) made from each patient's tumor, combined with an immunotherapy drug (PD-1 inhibitor), to prevent liver cancer from coming back after surgery. About 20 adults with early-stage liver cancer will receive the treatment. The …
Phase: PHASE1, PHASE2 • Sponsor: Yinghua Xu • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC